MXPA02004747A - Fluido cereborespinal artificial hiperoncotico y metodo para tratae edema de tejido neural con el mismo. - Google Patents

Fluido cereborespinal artificial hiperoncotico y metodo para tratae edema de tejido neural con el mismo.

Info

Publication number
MXPA02004747A
MXPA02004747A MXPA02004747A MXPA02004747A MXPA02004747A MX PA02004747 A MXPA02004747 A MX PA02004747A MX PA02004747 A MXPA02004747 A MX PA02004747A MX PA02004747 A MXPA02004747 A MX PA02004747A MX PA02004747 A MXPA02004747 A MX PA02004747A
Authority
MX
Mexico
Prior art keywords
therewith
cerebrospinal fluid
neural tissue
artificial cerebrospinal
tissue edema
Prior art date
Application number
MXPA02004747A
Other languages
English (en)
Inventor
Glenn Frazer
Original Assignee
Neuron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Therapeutics Inc filed Critical Neuron Therapeutics Inc
Publication of MXPA02004747A publication Critical patent/MXPA02004747A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71—Suction drainage systems
    • A61M1/77—Suction-irrigation systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0464—Cerebrospinal fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0693—Brain, cerebrum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA02004747A 1999-11-12 2000-11-08 Fluido cereborespinal artificial hiperoncotico y metodo para tratae edema de tejido neural con el mismo. MXPA02004747A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44003899A 1999-11-12 1999-11-12
US09/531,190 US6500809B1 (en) 1999-11-12 2000-03-21 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
PCT/US2000/042006 WO2001034225A2 (en) 1999-11-12 2000-11-08 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith

Publications (1)

Publication Number Publication Date
MXPA02004747A true MXPA02004747A (es) 2003-10-14

Family

ID=27032270

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004747A MXPA02004747A (es) 1999-11-12 2000-11-08 Fluido cereborespinal artificial hiperoncotico y metodo para tratae edema de tejido neural con el mismo.

Country Status (8)

Country Link
US (1) US6500809B1 (es)
EP (1) EP1235593A2 (es)
JP (1) JP2003513716A (es)
KR (1) KR20020073336A (es)
AU (1) AU2752101A (es)
CA (1) CA2388644A1 (es)
MX (1) MXPA02004747A (es)
WO (1) WO2001034225A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005870A2 (en) * 2000-07-19 2002-01-24 Neuron Therapeutics, Inc. Kits and compositions supporting intracranial perfusions
US6689756B2 (en) * 2001-03-02 2004-02-10 Integra Lifesciences Corporation Treatment of neurological disease
US20030060421A1 (en) * 2001-07-19 2003-03-27 Neuron Therapeutics, Inc. Kits and compositions supporting intracranial perfusions
WO2003020208A2 (en) * 2001-08-31 2003-03-13 Neuron Therapeutics, Inc. Treatment of neurologic hemorrhage
US7520862B2 (en) 2004-02-03 2009-04-21 Neuro Diagnostic Devices, Inc. Cerebral spinal fluid shunt evaluation system
US20080214951A1 (en) * 2004-02-03 2008-09-04 Neuro Diagnostic Devices, Inc. Cerebrospinal Fluid Evaluation Systems
CA2574679C (en) 2004-07-20 2013-06-04 Medtronic, Inc. Implantable cerebral spinal fluid drainage device and method of draining cerebral spinal fluid
US20060034946A1 (en) * 2004-08-13 2006-02-16 Yanming Wang Irrigating solution for neurosurgical procedures
US20060057065A1 (en) * 2004-09-11 2006-03-16 Yanming Wang Composition and method to prevent and treat brain and spinal cord injuries
US20060073098A1 (en) * 2004-10-02 2006-04-06 Yanming Wang Irrigating solution for neurosurgical procedures
US20060128797A1 (en) * 2004-12-15 2006-06-15 Yanming Wang Method and composition for resuscitation
JP5197003B2 (ja) * 2005-04-19 2013-05-15 株式会社大塚製薬工場 人工髄液
US7759309B2 (en) * 2006-05-19 2010-07-20 Yanming Wang Use of polypeptides in treating tissue injury
CA2721135A1 (en) 2007-06-13 2008-12-24 Wayne State University Board Of Governors A zwitterion solution for low-volume therapeutic delivery
CA2721134C (en) * 2007-06-13 2017-02-07 Wayne State University Board Of Governors A baclofen solution for low-volume therapeutic delivery
AU2009209515A1 (en) * 2008-01-28 2009-08-06 Milux Holding Sa Blood clot removal device, system, and method
WO2013169939A2 (en) * 2012-05-08 2013-11-14 Aeromics, Llc New methods
WO2015021513A1 (en) * 2013-08-16 2015-02-19 University Of Western Sydney Device for storing a tissue sample
WO2015069961A1 (en) 2013-11-06 2015-05-14 Aeromics, Llc Novel prodrug salts
CN108310008B (zh) * 2018-01-09 2020-12-18 中国人民解放军陆军军医大学第一附属医院 胶体金在制备人工脑脊液试剂中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1578776A (en) 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4378797A (en) 1980-04-14 1983-04-05 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4981691A (en) 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
US4393863A (en) 1980-04-14 1983-07-19 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4686085A (en) 1980-04-14 1987-08-11 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4840617A (en) 1980-04-14 1989-06-20 Thomas Jefferson University Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
US4532130A (en) 1981-07-06 1985-07-30 Rush-Presbyterian-St. Luke's Medical Center Preparation of synthetic frythrocytes
US4446154A (en) 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4425334A (en) 1982-04-02 1984-01-10 The Regents Of The University Of California Functional oxygen transport system
US4776991A (en) 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
CA1312009C (en) 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
WO1988006437A1 (en) 1987-02-27 1988-09-07 Terumo Kabushiki Kaisha Process for preparing liposome
US5449759A (en) 1987-05-16 1995-09-12 Somatogen, Inc. Hemoglobins with intersubunit desulfide bonds
US5061688A (en) 1988-08-19 1991-10-29 Illinois Institute Of Technology Hemoglobin multiple emulsion
US5128452A (en) 1989-04-19 1992-07-07 Baxter International Inc. Process for the production of crosslinked hemoglobin in the presence of sodium tripolyphosphate
US5599907A (en) 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
US5312808A (en) 1989-11-22 1994-05-17 Enzon, Inc. Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
DK0646130T3 (da) 1993-03-16 1997-06-02 Hemosol Inc Selektiv tværbinding af hæmoglobiner ved hjælp af oxiderede, ringåbnede saccharider
US5952470A (en) 1995-06-07 1999-09-14 Biopure Corporation Method for separating unmodified hemoglobin from cross-linked hemoglobin
US5691453A (en) 1995-06-07 1997-11-25 Biopure Corporation Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC

Also Published As

Publication number Publication date
JP2003513716A (ja) 2003-04-15
EP1235593A2 (en) 2002-09-04
CA2388644A1 (en) 2001-05-17
WO2001034225A2 (en) 2001-05-17
AU2752101A (en) 2001-06-06
WO2001034225A3 (en) 2002-07-11
KR20020073336A (ko) 2002-09-23
US6500809B1 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
MXPA02004747A (es) Fluido cereborespinal artificial hiperoncotico y metodo para tratae edema de tejido neural con el mismo.
EP1200086A4 (en) THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
AU2001237911A1 (en) System and method for determining stimulation parameters for the treatment of epileptic seizures
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
HK1048949A1 (en) Method and composition for the treatment of scars
IL162505A0 (en) Method for treatment of peripheral neural and vascular ailments
HK1020167A1 (en) Oxa acids and related compounds for treating skin conditions.
ZA961927B (en) Method of treating cardiac inflammatory disease.
AP2003002875A0 (en) Apparatus and method for treatment of water.
ZA997371B (en) Method of treating nitrate-induced tolerance.
AU8223998A (en) Method and apparatus for the electrochemical treatment of water and aqueous saltsolutions
IL137429A0 (en) Methods and compsitions for treating diseases and conditions of the eye
EP1197498A4 (en) METHOD FOR TREATING POLYMER RESIN
AU2001240046A1 (en) Method of treating skin conditions
HUP0200738A3 (en) Method of the treatment of incontinence
AU1034901A (en) Method and installation for treating effluents, comprising an additional treatment of the sludge by ozonisation
ZA971600B (en) Treatment of macular edema.
MXPA03004017A (es) Metodo para el tratamiento de inflamacion.
MXPA03004449A (es) Metodo cosmetico para tratar la piel.
ZA965346B (en) Methods of treating neuropeptide Y-associated conditions.
ZA200101188B (en) DNAzymes and methods for treating restenosis.
MXPA02001759A (es) Metodo para tratar la infestcion corporal de insectos.
ZA966970B (en) Water treatment method.
ZA200007396B (en) Method of treatment.
MXPA01012495A (es) Metodo para tratar la perdida capilar con el uso de derivados de difenilmetano.